1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate,
Amias,
Atacand,
Blopress,
candesartan cilexetil,
Kenzen,
Parapres,
TCV 116,
TCV-116,
Candesartan cilexetil,
145040-37-5,
Atacand,
TCV-116,
Amias,
Parapres,
Kenzen,
TCV 116,
Candesartan (Cilexetil),
CANDESARTAN CILEXTIL,
candesartancilexetil,
Candesartan cilexetil [USAN],
CHEMBL1014,
CHEBI:3348,
TCY 116,
C33H34N6O6,
MFCD00871371,
AK-75900,
1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)-,
2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester,
(+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester),
1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate,
1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate,
1-(cyclohexyloxycarbonyloxy)ethyl 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate,
1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-benzimidazole-7-carboxylate,
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate,
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate,
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, (+-)-,
2-ETHOXY-1-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID 1-[[(CYCLOHEXYLOXY)CARBONYL]OXY]ETHYL ESTER,
Racanda,
Candesartan hexetil,
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate,
candesartan cilexitil,
Spectrum_001707,
AC1L1DWQ,
DSSTox_CID_239,
Spectrum2_000485,
Spectrum3_000996,
Spectrum4_001124,
Spectrum5_001462,
DSSTox_RID_85567,
Candesartan-cilexetil-Atacand,
DSSTox_GSID_20239,
SCHEMBL40831,
BSPBio_002691,
KBioGR_001607,
KBioSS_002187,
MLS004774127,
Candesartan cilexetil , 97%,
SPECTRUM1504261,
SPBio_000349,
GTPL8352,
Candesartan cilexetil (Atacand),
DTXSID5020239,
KBio2_002187,
KBio2_004755,
KBio2_007323,
KBio3_001911,
KS-00000IVU,
EBD4212,
GHOSNRCGJFBJIB-UHFFFAOYSA-N,
HMS1922J09,
HMS2093E20,
HMS3651I08,
Pharmakon1600-01504261,
BCP22050,
Candesartan cilexetil (JP17/USAN),
Tox21_302202,
AC-204,
BDBM50318907,
BG0573,
CCG-39530,
NSC758697,
s2037,
STL451065,
AKOS015894954,
AKOS015920180,
AB07617,
AM90293,
AN-7256,
BCP9000480,
CCG-222334,
CS-2893,
DB00796,
DS-1302,
KS-1147,
NSC-758697,
VA10473,
Candesartan cilexetil, >=98% (HPLC),
NCGC00095123-01,
NCGC00095123-02,
NCGC00095123-03,
NCGC00255218-01,
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate,
BC209195,
BR-75900,
HY-17505,
LS-32741,
SC-12740,
SMR003500784,
SBI-0206767.P001,
AB0012012,
AB2000442,
TL8000995,
4CH-009595,
C-265,
CAS-145040-37-5,
FT-0082579,
FT-0602914,
ST24030238,
SW220041-1,
A-2005,
C07709,
D00626,
J10436,
AB01274805-01,
AB01274805_02,
AB01274805_03,
040C375,
H212/91,
L006257,
SR-05000001976,
Atacand;Amias;Blopress;Ratacand;TCV 116;TCY 116,
Camptothecine, Antibiotic for Culture Media Use Only,
I06-0090,
Q-200786,
SR-05000001976-1,
BRD-A65671304-001-02-6,
BRD-A65671304-001-03-4,
Candesartan cilexetil, European Pharmacopoeia (EP) Reference Standard,
Candesartan cilexetil, United States Pharmacopeia (USP) Reference Standard,
Candesartan cilexetil for peak identification, European Pharmacopoeia (EP) Reference Standard,
Candesartan cilexetil for system suitability, European Pharmacopoeia (EP) Reference Standard,
Candesartan Cilexetil, Pharmaceutical Secondary Standard; Certified Reference Material,
(+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methylbenzimidazole-7-carboxylate,
(+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate,
1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate,
1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethox,
1-(Cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylate,
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate,
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-benzodiazole-4-carboxylate,
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-benzodiazole-4-carboxylate,
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl] methyl]benzimidazole-4-carboxylate,
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate.,
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, ( -)-,
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester,
2-Ethoxy-1-[2'-(1H-tetrazole-5-yl)-4-biphenylylmethyl]-1H-benzimidazole-7-carboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester,
2-Ethoxy-3-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester,
2-Ethoxy-3-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester,
2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe,
Blopress,
candesartan,
Ratacand,
Atacand (TN),
ATACAND HCT,
UNII-R85M2X0D68,
PBCMNDESARTAN CILEXETIL,
CID2540,
R85M2X0D68,
C33-H34-N6-O6,
ACN-037206,
CS-O-00538,
C2635,
C077793,
Candesartan cilexetil, 98%, an ATR antagonist - 1G 1g,